RECRUITINGOBSERVATIONAL
Observational Study of Iris Tumors
About This Trial
This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.
Who May Be Eligible (Plain English)
Inclusion Criteria for tumor group:
- Eyes with diagnosis of melanotic or amelanotic iris tumors
Inclusion Criteria for healthy control group:
- Eyes without iris defects or lesions
Exclusion Criteria (both groups):
- Inability to give willing to sign a consent form
- Inability to maintain stable fixation for OCT imaging
- Inability to commit to required study visits
- Eyes with concurrent retinal diseases, glaucoma, or conditions that in the opinion of the investigators might affect iris circulation
- Mature cataracts if found to limit visual potential to worse than 20/40
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria for tumor group:
* Eyes with diagnosis of melanotic or amelanotic iris tumors
Inclusion Criteria for healthy control group:
* Eyes without iris defects or lesions
Exclusion Criteria (both groups):
* Inability to give informed consent
* Inability to maintain stable fixation for OCT imaging
* Inability to commit to required study visits
* Eyes with concurrent retinal diseases, glaucoma, or conditions that in the opinion of the investigators might affect iris circulation
* Mature cataracts if found to limit visual potential to worse than 20/40
Locations (1)
Oregon Health & Science University
Portland, Oregon, United States